Phase II study of high-dose intermittent cycloleucine in colorectal malignancies.
D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000008:administration & dosage*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003515:Cycloleucine / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000596:Amino Acids; D003515:Cycloleucine